Piper Jaffray Companies
Edit

Piper Jaffray Companies

https://www.piperjaffray.com/
Last activity: 07.03.2025
Probably Closed
Categories: BrokerBusinessFinTechFirmLifeManagementMarketProductResearchService
Founded in 1895, Piper Jaffray is headquartered in Minneapolis with more than 50 offices across the U.S. and in London, Aberdeen, Zurich and Hong Kong. We offer a full suite of products to serve our clients’ business lifecycle needs, geographic reach in an increasingly global market, and deep expertise in our core sectors.

© 2017 Piper Jaffray Companies. Since 1895.
Likes
2
Mentions
53
Location: Liberia, Montserrado
Phone: +1 612-303-6000
Founded date: 1895

Mentions in press and media 53

DateTitleDescription
07.03.2025AppLovin short-seller urges exclusion of the stock from S&P 500 indexShort-seller firm Fuzzy Panda Research sent a letter to the S&P 500 Index Committee this week, urging the group to keep the stock out of the benchmark index. Fuzzy Panda has accused AppLovin of using fraudulent tactics to bolster its on...
14.01.2025Saluda Medical Secures $100 Million to Revolutionize Pain ManagementIn the world of medical innovation, funding is the lifeblood that fuels progress. Saluda Medical, a Minneapolis-based company, has just secured a hefty $100 million in financing. This investment is not just a number; it represents hope for ...
13.01.2025Saluda Medical Raises $100M in FundingSaluda Medical, a Minneapolis, MN-based commercial-stage medical device company, raised $100M in funding. The round was led by Redmile Group, with participation from existing investors Wellington Management, TPG Life Sciences Innovation, Fi...
13.01.2025Saluda Medical: $100 Million Of Financing ClosedSaluda Medical – a commercial-stage medical device company focused on developing treatments for chronic neurological conditions utilizing a novel closed-loop and dose-control neuromodulation platform – announced the closing of a $100 millio...
04.12.2024Maze Therapeutics Secures $115 Million to Revolutionize Kidney Disease TreatmentMaze Therapeutics, a beacon of innovation in the biopharmaceutical landscape, has successfully raised $115 million in a Series D financing round. This funding marks a significant milestone for the South San Francisco-based company, which is...
03.12.2024Maze Therapeutics: $115 Million (Series D) Raised To Develop Precision MedicineMaze Therapeutics, a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small-molecule precision medicines for patients living with renal, cardiovascular, and metabolic diseases, announced the ...
20.11.2024Alentis Therapeutics: $181.4 Million (Series D) Raised For Advancing Clinical Development Of Anti-Claudin-1 ADCsAlentis Therapeutics – a clinical-stage biotechnology company developing treatments for Claudin-1 positive (CLDN1+) tumors and organ fibrosis – announced that it has raised $181.4 million in Series D financing, supported by a syndicate of t...
13.11.2024Alentis Therapeutics Secures $181.4 Million to Pioneer Cancer TreatmentsIn a bold move to reshape cancer treatment, Alentis Therapeutics has successfully raised $181.4 million in an oversubscribed Series D funding round. This infusion of capital, led by OrbiMed and co-led by Novo Holdings and Jeito Capital, sig...
13.11.2024Alentis Therapeutics: $181.4 Million (Series D) Raised To Develop Treatments For Claudin-1 TumorsAlentis Therapeutics – a clinical-stage biotechnology company developing treatments for Claudin-1 positive (CLDN1+) tumors and organ fibrosis – announced that it has raised $181.4 million in Series D funding, supported by a syndicate of top...
10.10.2019Teens Prefer Watching YouTube Over Netflix, Survey RevealsDiane Samson, Tech Times 10 October 2019, 07:10 am (Photo : Gary Cassel | Pixabay) Netflix is no longer the leading video platform among young people in the latest survey by Piper Jaffray. Analysts believe that the wide variety of content o...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In